Tuba Esfandyari
Expertise in
20
conditions

Dr. Tuba Esfandyari

Gastroenterology
10720 Nall Avenue, 
Overland Park, KS 
On Staff At
Accepting New Patients
Offers Telehealth
32 Years of Experience
Expertise in
20
conditions
10720 Nall Avenue, 
Overland Park, KS 

Overview

Tuba Esfandyari is a Gastroenterologist in Overland Park, Kansas. Dr. Esfandyari has been practicing medicine for over 32 years is highly rated in 20 conditions, according to our data. Her top areas of expertise are Gastroparesis, Encopresis, Bowel Incontinence, Gastrectomy, and Endoscopy. Dr. Esfandyari is currently accepting new patients.

Her clinical research consists of co-authoring 17 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

Tabriz University Of Medical Sciences And Health Services, Doctor Of Medicine, 1994

Residency

University of Massachusetts Medical School, Internal Medicine, 2003

Specialties

Gastroenterology

Licenses

Internal Medicine in MN

Board Certifications

American Board Of Internal Medicine, Gastroenterology - 2006

Fellowships

Mayo Clinic Health System, Gastroenterology, 2006

Hospital Affiliations

Olathe Medical Center
University Of Kansas Hospital

Languages Spoken

English
Farsi

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Home State Health
  • EPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MVP Health
  • EPO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sunflower Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 17 Less Insurance Carriers -

Locations

Ambulatory Surgery Center
10720 Nall Avenue, Overland Park, KS 66211
Other Locations
College Square Medical Pavilion
12000 West 110th Street, Overland Park, KS 66210
KU MedWest
7405 Renner Road, Shawnee, KS 66217

Additional Areas of Focus

Dr. Esfandyari has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

PillCam SB3 Registry for Development and Validation of Improved Algorithms for GI Pathologies Detection
PillCam SB3 Registry for Development and Validation of Improved Algorithms for GI Pathologies Detection
Enrollment Status: Completed
Publish Date: October 27, 2025
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
Enrollment Status: Completed
Publish Date: October 14, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
A Phase II Randomized, Placebo Controlled, Double-blind, 4 Arms Dose-ranging Study to Evaluate the Efficacy and Safety of SHR0302 Compared to Placebo in Patients With Moderate to Severe Active Ulcerative Colitis.
A Phase II Randomized, Placebo Controlled, Double-blind, 4 Arms Dose-ranging Study to Evaluate the Efficacy and Safety of SHR0302 Compared to Placebo in Patients With Moderate to Severe Active Ulcerative Colitis.
Enrollment Status: Completed
Publish Date: June 02, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of Velusetrag for the Treatment of Diabetic or Idiopathic Gastroparesis
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of Velusetrag for the Treatment of Diabetic or Idiopathic Gastroparesis
Enrollment Status: Completed
Publish Date: April 17, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

17 Total Publications

Short-term and Long-term Efficacy of Gastric Peroral Endoscopic Myotomy for Refractory Gastroparesis: A Meta-analysis.
Short-term and Long-term Efficacy of Gastric Peroral Endoscopic Myotomy for Refractory Gastroparesis: A Meta-analysis.
Journal: Journal of clinical gastroenterology
Published: April 16, 2025
Similar Doctors
Ajay Bansal
Expertise in
15
conditions
Dr. Ajay Bansal
Gastroenterology
Expertise in
15
conditions
Dr. Ajay Bansal
Gastroenterology

Ambulatory Surgery Center

10720 Nall Avenue, 
Overland Park, KS 
 (8.9 miles away)
913-588-1227
Experience:
29+ years
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Ajay Bansal is a Gastroenterologist in Overland Park, Kansas. Dr. Bansal has been practicing medicine for over 29 years is highly rated in 15 conditions, according to our data. His top areas of expertise are Barrett Esophagus, Colorectal Polyps, Gastroesophageal Reflux Disease (GERD), Colonoscopy, and Endoscopy. Dr. Bansal is currently accepting new patients.

Amit Rastogi
Expertise in
44
conditions
Dr. Amit Rastogi
Gastroenterology
Expertise in
44
conditions
Dr. Amit Rastogi
Gastroenterology

Ambulatory Surgery Center

10720 Nall Avenue, 
Overland Park, KS 
 (8.9 miles away)
913-588-1227
Experience:
34+ years
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Amit Rastogi is a Gastroenterologist in Overland Park, Kansas. Dr. Rastogi has been practicing medicine for over 34 years is highly rated in 44 conditions, according to our data. His top areas of expertise are Colorectal Polyps, Hereditary Pancreatitis, Acute Pancreatitis, Endoscopy, and Colonoscopy. Dr. Rastogi is currently accepting new patients.

Salih Samo
Expertise in
14
conditions
Dr. Salih Samo
Gastroenterology
Expertise in
14
conditions
Dr. Salih Samo
Gastroenterology

Ambulatory Surgery Center

10720 Nall Avenue, 
Overland Park, KS 
 (8.9 miles away)
913-588-1227
Experience:
16+ years
Languages Spoken:
English, Arabic, Kurdish
See accepted insurances
Accepting New Patients
Offers Telehealth

Salih Samo is a Gastroenterologist in Overland Park, Kansas. Dr. Samo has been practicing medicine for over 16 years is highly rated in 14 conditions, according to our data. His top areas of expertise are Mesenteric Artery Ischemia, Achalasia, Benign Esophageal Stricture, Endoscopy, and Colonoscopy. Dr. Samo is currently accepting new patients.

Frequently Asked Questions about Dr. Tuba Esfandyari

How do I make an appointment with Dr. Tuba Esfandyari?

You can book an appointment with Dr. Tuba Esfandyari by calling their office at 913-588-1227. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Tuba Esfandyari a top-rated expert for Gastroparesis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Tuba Esfandyari is classified as an Distinguished expert for Gastroparesis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Tuba Esfandyari specialize in?

While Dr. Tuba Esfandyari is a Gastroenterology, they have specific expertise in Gastroparesis, Gastrectomy, and Encopresis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Tuba Esfandyari participate in research or clinical trials?

Yes. Dr. Tuba Esfandyari has published 17 articles and abstracts on conditions like Gastroparesis. You can view a list of Dr. Tuba Esfandyari's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Tuba Esfandyari accept my insurance?

Dr. Tuba Esfandyari accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 913-588-1227 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Esfandyari's expertise for a condition
ConditionClose
    View All 19 Advanced Conditions
    View All 53 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile